Springer Nature
Browse
12933_2022_1549_MOESM4_ESM.tif (1.28 MB)

Additional file 4 of The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study

Download (1.28 MB)
figure
posted on 2022-06-29, 06:28 authored by Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, Hsin-Fu Lee, Pei-Ru Li, Wei-Min Chen, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See, Gregory Y. H. Lip
Additional file 4: Figure S3. Subgroup analysis of forest plot of HR for GLP-1RA versus DPP4i among patients with T2D after PSM. There was no difference of the risk of incident AF between the GLP-1RA and DPP4i across all subgroups (P interaction > 0.05).

Funding

Ministry of Science and Technology Chang Gung Memorial Hospital

History

Usage metrics

    Cardiovascular Diabetology

    Categories

    Keywords

    Atrial fibrillationType 2 diabetes mellitusSodium-glucose cotransporter-2 inhibitorGlucagon-like peptide-1 receptor agonistDipeptidyl peptidase-4 inhibitor

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC